Indefinite Delivery Contract 36C24122D0027

Award Date 9/15/22
Last Date to Order 9/1/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award indefinite delivery contract to Roche Diagnostics Corporation for Roche Ventana reagents. The contract includes three firm fixed price delivery orders totaling $2,275,000, $455,000.04, and $2,251,572.95 respectively, with a period of performance from October 2021 through October 2026. Place of performance is in Castleton, Indiana. The reagents supplied under this...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded an indefinite-delivery contract to Roche Diagnostics Corporation to provide reagents, consumables, chemicals, and laboratory testing materials. Over the past four years, multiple delivery orders have been placed against this contract vehicle valued at $124,700.93 to $317,191.19 with periods of performance ranging from December 2020 through November 2024. Places of performance for...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract valued at $5,223,493.58 to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. Under this multiple award IDV, Roche will provide VENTANA histology reagents and supplies to support laboratory operations at VA medical centers in the VISN 1 network covering the northeastern U.S. The...
Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The contract has a potential value of $1,115,564.58 to provide reagents and supplies with no set-aside designation. Performance will take place through January 31, 2028. Under this contract, Roche Diagnostics was issued a $210,121.69 firm fixed price delivery order for reagents and supplies. The delivery...
This federal contract IDV award by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides for the delivery of reagents over a period of 3 years from October 1, 2024 to September 30, 2027. The contract, valued at $225,409.54, is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA-VHA VISN 17) awarded a single-award Indefinite Delivery Contract (IDC) valued at $1,963,596.60 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide Roche Ventana reagents and consumables. This 5-year IDC serves as a vehicle for the VA to issue fixed-price delivery orders against, as needed, to support pathology and histology services at VA medical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide laboratory testing supplies and equipment. The IDV has a potential value of $6.5 million and period of performance through June 2027. Three delivery orders have been issued against the contract to date for a total of $246,135.04, $231,704.12, and $13,824 for reagents, supplies, and molecular testing systems...
This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at a ceiling of $389,666.38, provides the VA with a 5-year ordering period to acquire Roche's clinical chemistry analyzers, reagents, and testing services to support immunochemistry, hematology, molecular diagnostics,...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a series of firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The total ceiling value of the IDC is $2,403,690.00, with the most recent delivery order valued at $480,738.00 and a performance period ending on September 30, 2025. The delivery orders are...
The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 23 (VISN 23), awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp., for the delivery of microbiology reagents to the Minneapolis VA Medical Center. The contract, valued at up to $1,989,999.99, has a period of performance through September 30, 2029. Under this IDC, the VA issued a $380,057.46 firm-fixed-price delivery order to Roche...
  • 36C24122D0027
    Indefinite Delivery Contract
  • 8
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Roche Diagnostics Corporation an indefinite delivery contract for reagents. The IDV has a potential value of $700,000 and a period of performance through September 1, 2027. No set-aside was used.

Under the IDV, Roche Diagnostics has received multiple delivery orders for reagents to support medical testing programs across VISN 1 facilities. Delivery orders ranged in value from approximately $3,800 to $45,000, with periods of performance from one year to four years. Places of performance included medical centers and laboratories in Boston and Brockton, Massachusetts. The reagents are intended to support the VA-VHA's mission to provide healthcare services and medical testing to eligible veterans through its integrated network of facilities in New England.

The original pre-solicitation notice indicated the VA's intent to award a sole source contract to Roche Diagnostics for reagents for tissue staining systems. The authority cited was the exception for licensing agreements as the only reasonably available source. This IDV and associated delivery orders aim to procure laboratory supplies and reagents necessary to operate medical testing equipment and support testing programs serving veterans in the Boston region.

Generated 1/5/24, 7:53 PM